Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer

Siegel, 2021, Cancer statistics, 2021, CA Cancer J Clin, 71, 7, 10.3322/caac.21654 Matulonis, 2016, Ovarian cancer, Nat Rev Dis Primers, 2, 10.1038/nrdp.2016.61 Lheureux, 2019, Epithelial ovarian cancer: evolution of management in the era of precision medicine, CA Cancer J Clin, 69, 280, 10.3322/caac.21559 Reid, 2017, Epidemiology of ovarian cancer: a review, Cancer Biol Med, 14, 9, 10.20892/j.issn.2095-3941.2016.0084 Lynch, 2009, Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management, Mol Oncol, 3, 97, 10.1016/j.molonc.2009.02.004 Goode, 2010, A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24, Nat Genet, 42, 874, 10.1038/ng.668 Kuroki, 2020, Treatment of epithelial ovarian cancer, BMJ, 371, m3773, 10.1136/bmj.m3773 Kurnit, 2021, Updates and new options in advanced epithelial ovarian cancer treatment, Obstet Gynecol, 137, 108, 10.1097/AOG.0000000000004173 Pushpakom, 2019, Drug repurposing: progress, challenges and recommendations, Nat Rev Drug Discov, 18, 41, 10.1038/nrd.2018.168 Schcolnik-Cabrera, 2021, Perspectives on drug repurposing, Curr Med Chem, 28, 2085, 10.2174/0929867327666200831141337 Sleire, 2017, Drug repurposing in cancer, Pharmacol Res, 124, 74, 10.1016/j.phrs.2017.07.013 Tran, 2020, Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy, Lancet Oncol, 21, 1134, 10.1016/S1470-2045(20)30424-1 Pantziarka, 2021, A database of drug repurposing clinical trials in oncology, Front Pharmacol, 12, 10.3389/fphar.2021.790952 Barbosa, 2019, Niclosamide repositioning for treating cancer: challenges and nano-based drug delivery opportunities, Eur J Pharm Biopharm, 141, 58, 10.1016/j.ejpb.2019.05.004 Jin, 2010, Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species, Cancer Res, 70, 2516, 10.1158/0008-5472.CAN-09-3950 Osada, 2011, Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations, Cancer Res, 71, 4172, 10.1158/0008-5472.CAN-10-3978 Lu, 2011, Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway, PLoS One, 6, 10.1371/journal.pone.0029290 Sack, 2011, Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer, J Natl Cancer Inst, 103, 1018, 10.1093/jnci/djr190 Yo, 2012, Growth inhibition of ovarian tumor-initiating cells by niclosamide, Mol Cancer Therapeut, 11, 1703, 10.1158/1535-7163.MCT-12-0002 Li, 2013, Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer, Mol Cancer Therapeut, 12, 2200, 10.1158/1535-7163.MCT-13-0095 Wieland, 2013, Anticancer effects of niclosamide in human glioblastoma, Clin Cancer Res, 19, 4124, 10.1158/1078-0432.CCR-12-2895 You, 2014, Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer, Mol Cancer Therapeut, 13, 606, 10.1158/1535-7163.MCT-13-0608 Londoño-Joshi, 2014, Effect of niclosamide on basal-like breast cancers, Mol Cancer Therapeut, 13, 800, 10.1158/1535-7163.MCT-13-0555 Arend, 2014, Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer, Gynecol Oncol, 134, 112, 10.1016/j.ygyno.2014.04.005 Liu, 2014, Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer, Clin Cancer Res, 20, 3198, 10.1158/1078-0432.CCR-13-3296 King, 2015, WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer, Oncogene, 34, 3452, 10.1038/onc.2014.277 Liao, 2015, The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways, Curr Cancer Drug Targets, 15, 726, 10.2174/1568009615666150629132157 Chen, 2017, Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling, Gastroenterology, 152, 2022, 10.1053/j.gastro.2017.02.039 Yu, 2018, Niclosamide exhibits potent anticancer activity and synergizes with sorafenib in human renal cell cancer cells, Cell Physiol Biochem, 47, 957, 10.1159/000490140 Schweizer, 2018, A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer, PLoS One, 13, 10.1371/journal.pone.0198389 Burock, 2018, Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or synchronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial, BMC Cancer, 18, 297, 10.1186/s12885-018-4197-9 Deng, 2016, A blockade of IGF signaling sensitizes human ovarian cancer cells to the anthelmintic niclosamide-induced anti-proliferative and anticancer activities, Cell Physiol Biochem, 39, 871, 10.1159/000447797 Mao, 2021, Argonaute (AGO) proteins play an essential role in mediating BMP9-induced osteogenic signaling in mesenchymal stem cells (MSCs), Genes Dis, 8, 918, 10.1016/j.gendis.2021.04.004 Ni, 2021, A one-step construction of adenovirus (OSCA) system using the Gibson DNA Assembly technology, Mol Ther Oncolytics, 23, 602, 10.1016/j.omto.2021.11.011 Wu, 2021, Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs), Genes Dis, 8, 814, 10.1016/j.gendis.2021.01.004 Huang, 2021, Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways, Aging, 13, 17407, 10.18632/aging.203232 Cui, 2021, All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members, Genes Dis, 8, 509, 10.1016/j.gendis.2019.12.012 Luther, 2013, IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma, Cancer Lett, 336, 222, 10.1016/j.canlet.2013.05.002 Su, 2011, Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma, Oncogene, 30, 3907, 10.1038/onc.2011.97 Deng, 2015, Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells, Sci Rep, 5, 10.1038/srep17523 Yu, 2018, Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs), Genes Dis, 5, 137, 10.1016/j.gendis.2018.04.003 Shu, 2018, A simplified system to express circularized inhibitors of miRNA for stable and potent suppression of miRNA functions, Mol Ther Nucleic Acids, 13, 556, 10.1016/j.omtn.2018.09.025 Shu, 2018, Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation, J Cell Biochem, 119, 8872, 10.1002/jcb.27140 Luo, 2004, Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells, J Biol Chem, 279, 55958, 10.1074/jbc.M407810200 Huang, 2020, Microvesicles (MIVs) secreted from adipose-derived stem cells (ADSCs) contain multiple microRNAs and promote the migration and invasion of endothelial cells, Genes Dis, 7, 225, 10.1016/j.gendis.2019.04.005 Si, 2006, CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells, Mol Cell Biol, 26, 2955, 10.1128/MCB.26.8.2955-2964.2006 Zhou, 2003, Tyrosine kinase inhibitor STI-571/gleevec down-regulates the β-catenin signaling activity, Cancer Lett, 193, 161, 10.1016/S0304-3835(03)00013-2 Shu, 2020, ARRB1-promoted NOTCH1 degradation is suppressed by OncomiR miR-223 in T-cell acute lymphoblastic leukemia, Cancer Res, 80, 988, 10.1158/0008-5472.CAN-19-1471 Zhang, 2015, TqPCR: a touchdown qPCR assay with significantly improved detection sensitivity and amplification efficiency of SYBR green qPCR, PLoS One, 10 Fan, 2017, Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors, Oncotarget, 8, 27105, 10.18632/oncotarget.15637 Liu, 2020, Highly expressed BMP9/GDF2 in postnatal mouse liver and lungs may account for its pleiotropic effects on stem cell differentiation, angiogenesis, tumor growth and metabolism, Genes Dis, 7, 235, 10.1016/j.gendis.2019.08.003 He, 2022, OUHP: an optimized universal hairpin primer system for cost-effective and high-throughput RT-qPCR-based quantification of microRNA (miRNA) expression, Nucleic Acids Res, 50, e22, 10.1093/nar/gkab1153 Zeng, 2020, A reverse transcriptase-mediated ribosomal RNA depletion (RTR2D) strategy for the cost-effective construction of RNA sequencing libraries, J Adv Res, 24, 239, 10.1016/j.jare.2019.12.005 Gao, 2013, Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways, Oncol Rep, 30, 292, 10.3892/or.2013.2438 He, 2011, Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer, Mol Pharmacol, 79, 211, 10.1124/mol.110.068668 Wang, 2021, Development of a simplified and inexpensive RNA depletion method for plasmid DNA purification using size selection magnetic beads (SSMBs), Genes Dis, 8, 298, 10.1016/j.gendis.2020.04.013 Fan, 2020, A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells, Cancer Gene Ther, 27, 424, 10.1038/s41417-019-0113-y Liao, 2017, Characterization of retroviral infectivity and superinfection resistance during retrovirus-mediated transduction of mammalian cells, Gene Ther, 24, 333, 10.1038/gt.2017.24 Luo, 2010, TGFβ/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells, J Biol Chem, 285, 29588, 10.1074/jbc.M110.130518 Zeng, 2018, The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs, Genes Dis, 5, 62, 10.1016/j.gendis.2018.02.001 Zhao, 2019, A pH-triggered, self-assembled, and bioprintable hybrid hydrogel scaffold for mesenchymal stem cell based bone tissue engineering, ACS Appl Mater Interfaces, 11, 8749, 10.1021/acsami.8b19094 Zou, 2017, Gelatin-derived graphene-silicate hybrid materials are biocompatible and synergistically promote BMP9-induced osteogenic differentiation of mesenchymal stem cells, ACS Appl Mater Interfaces, 9, 15922, 10.1021/acsami.7b00272 Luo, 2008, Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects, Lab Invest, 88, 1264, 10.1038/labinvest.2008.98 Zhao, 2021, A functional autophagy pathway is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs), Am J Transl Res, 13, 4233 Huang, 2012, Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells, J Bone Miner Res, 27, 1566, 10.1002/jbmr.1622 Wang, 2018, Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway, Sci Rep, 8, 10.1038/s41598-018-36214-5 Zhao, 2020, The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition, Am J Transl Res, 12, 8084 Gou, 2022, Carboxymethyl chitosan prolongs adenovirus-mediated expression of IL-10 and ameliorates hepatic fibrosis in a mouse model, Bioeng Transl Med, 7, 10.1002/btm2.10306 Hu, 2017, CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs), Oncotarget, 8, 111847, 10.18632/oncotarget.22915 He, 2020, FAMSi: a synthetic biology approach to the fast assembly of multiplex siRNAs for silencing gene expression in mammalian cells, Mol Ther Nucleic Acids, 22, 885, 10.1016/j.omtn.2020.10.007 Wang, 2019, Developing a versatile shotgun cloning strategy for single-vector-based multiplex expression of short interfering RNAs (siRNAs) in mammalian cells, ACS Synth Biol, 8, 2092, 10.1021/acssynbio.9b00203 Zhang, 2020, Leptin potentiates BMP9-induced osteogenic differentiation of mesenchymal stem cells through the activation of JAK/STAT signaling, Stem Cell Dev, 29, 498, 10.1089/scd.2019.0292 Cao, 2020, Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma, Am J Cancer Res, 10, 3248 An, 2021, Bone morphogenetic protein 4 (BMP4) promotes hepatic glycogen accumulation and reduces glucose level in hepatocytes through mTORC2 signaling pathway, Genes Dis, 8, 531, 10.1016/j.gendis.2020.11.004 Zhong, 2021, BMP4 augments the survival of hepatocellular carcinoma (HCC) cells under hypoxia and hypoglycemia conditions by promoting the glycolysis pathway, Am J Cancer Res, 11, 793 Zhong, 2022, Reversibly immortalized keratinocytes (iKera) facilitate re-epithelization and skin wound healing: potential applications in cell-based skin tissue engineering, Bioact Mater, 9, 523, 10.1016/j.bioactmat.2021.07.022 Liu, 2022, Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma, Genes Dis, 9, 1624, 10.1016/j.gendis.2021.12.020 Zhang, 2006, Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line, BMC Cancer, 6, 224, 10.1186/1471-2407-6-224 Shen, 2012, Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes, Pharmacol Rev, 64, 706, 10.1124/pr.111.005637 Amable, 2016, Cisplatin resistance and opportunities for precision medicine, Pharmacol Res, 106, 27, 10.1016/j.phrs.2016.01.001 Makovec, 2019, Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy, Radiol Oncol, 53, 148, 10.2478/raon-2019-0018 Parker, 1991, Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation, J Clin Invest, 87, 772, 10.1172/JCI115080 Zhen, 1992, Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines, Mol Cell Biol, 12, 3689 Lai, 1988, Enhanced DNA repair and resistance to cisplatin in human ovarian cancer, Biochem Pharmacol, 37, 4597, 10.1016/0006-2952(88)90325-5 Yao, 1995, Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines, Cancer Res, 55, 4367 Perego, 1998, Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol, Ann Oncol, 9, 423, 10.1023/A:1008265012435 Judson, 1999, Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy, Cancer Res, 59, 2425 Li, 2017, Inhibition of Wnt/β-catenin by anthelmintic drug niclosamide effectively targets growth, survival, and angiogenesis of retinoblastoma, Am J Transl Res, 9, 3776 Wang, 2018, The antihelminthic niclosamide inhibits cancer stemness, extracellular matrix remodeling, and metastasis through dysregulation of the nuclear β-catenin/c-myc axis in OSCC, Sci Rep, 8 Lu, 2018, Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide, Oncogene, 37, 5292, 10.1038/s41388-018-0340-y Li, 2014, Multi-targeted therapy of cancer by niclosamide: a new application for an old drug, Cancer Lett, 349, 8, 10.1016/j.canlet.2014.04.003